Alnylam Pharmaceuticals
ALNY
#445
Rank
$52.82 B
Marketcap
$399.86
Share price
-1.93%
Change (1 day)
65.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $491.22 USD on 2025-10-20

Lowest end of day price: $3.95 USD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 74.53%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$69.61 0.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$782.45 0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.94 3.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.30-2.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.16 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$139.16 1.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$48.39 0.75%๐Ÿ‡ซ๐Ÿ‡ท France
$31.41 0.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel